Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Active not recruiting 3Unknown 2Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 103Breast Neoplasms 80Neoplasms 74Neoplasm Metastasis 64Melanoma 64Leukemia, Myeloid, Acute 58Lymphoma, Non-Hodgkin 53Ovarian Neoplasms 52Multiple Myeloma 50Glioblastoma 49Colorectal Neoplasms 49Prostatic Neoplasms 48Pancreatic Neoplasms 47Lung Neoplasms 45Recurrence 42Carcinoma, Renal Cell 41Leukemia, Lymphocytic, Chronic, B-Cell 38Squamous Cell Carcinoma of Head and Neck 36Triple Negative Breast Neoplasms 34Myelodysplastic Syndromes 31Glioma 29Stomach Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell 27Brain Neoplasms 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 25Lymphoma 25Endometrial Neoplasms 24Carcinoma, Hepatocellular 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Advanced Solid Cancer × Clear all
NCT05947474 2026-02-10

ORB

Orionis Biosciences Inc

Phase 1 Active not recruiting
55 enrolled

Advanced Solid Cancer

NCT04877717 2025-03-25

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
107 enrolled

Advanced Solid Cancer

NCT03791112 2025-01-27

A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor

Betta Pharmaceuticals Co., Ltd.

Phase 1 Active not recruiting
54 enrolled

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡